Intermolecular Inc (NASDAQ:IMI) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Intermolecular Inc (NASDAQ:IMI) have been assigned a consensus recommendation of “Buy” from the two ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and one has assigned a buy rating to the company.

Shares of IMI stock remained flat at $$1.20 during trading hours on Tuesday. Intermolecular has a twelve month low of $0.88 and a twelve month high of $1.25. The stock has a fifty day simple moving average of $1.19 and a two-hundred day simple moving average of $1.18. The company has a current ratio of 4.74, a quick ratio of 4.74 and a debt-to-equity ratio of 0.43.

Several hedge funds have recently made changes to their positions in the stock. Gabelli Funds LLC bought a new stake in shares of Intermolecular during the 2nd quarter worth $2,421,000. Renaissance Technologies LLC grew its position in Intermolecular by 6.5% in the second quarter. Renaissance Technologies LLC now owns 1,583,367 shares of the semiconductor company’s stock valued at $1,853,000 after acquiring an additional 96,689 shares during the last quarter. GABELLI & Co INVESTMENT ADVISERS INC. bought a new position in Intermolecular in the second quarter valued at about $1,656,000. Water Island Capital LLC bought a new position in Intermolecular in the second quarter valued at about $1,167,000. Finally, Vanguard Group Inc. raised its stake in Intermolecular by 145.0% during the second quarter. Vanguard Group Inc. now owns 854,257 shares of the semiconductor company’s stock worth $999,000 after acquiring an additional 505,600 shares in the last quarter. Institutional investors and hedge funds own 61.05% of the company’s stock.

About Intermolecular

Intermolecular, Inc engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods.

Featured Article: Asset Allocation

Receive News & Ratings for Intermolecular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular and related companies with's FREE daily email newsletter.